RxDoctor Payments Data

Rachel March, NP

Family · Waterford, OHNPI 1780086538

Payments from drug & device makers

$568in general payments, 2019–2025

Across 31 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$146
  • Lilly USA, LLC$116
  • AbbVie$112
  • Johnson & Johnson$65
  • Bayer$60
  • Exact Sciences$20
  • plus $49 from 3 others

What the payments were for

  • Food & beverage$568100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$568 in reported general payments places this provider in the 60th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$29,430
Medicare patients
144
Services billed
395

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide85$97,941
JardianceEmpagliflozin74$80,849
MounjaroTirzepatide56$65,494
TrulicityDulaglutide47$47,680
EliquisApixaban43$38,957
XareltoRivaroxaban41$33,536
LinzessLinaclotide36$31,933
FarxigaDapagliflozin Propanediol27$26,665
ArexvyRsvpref3 Antigen/As01e/Pf67$20,411
Breztri AerosphereBudesonide/Glycopyr/Formoterol23$19,926
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$12,219
JanuviaSitagliptin Phosphate16$10,193
ShingrixVaricella-Zoster Ge/As01b/Pf43$9,425
Breo ElliptaFluticasone/Vilanterol15$9,086
MyrbetriqMirabegron15$6,938

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$116$113,174103 claims
Novo NordiskOzempic$146$97,94185 claims
GSKArexvy, Anoro Ellipta, Shingrix, Breo Ellipta$15$51,141141 claims
PfizerEliquis$15$38,95743 claims
AbbVieLinzess, Synthroid$112$33,80564 claims
Johnson & JohnsonXarelto$65$33,53641 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 6,812 family providers in Ohio.

Other family in Waterford

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →